Jiangsu Tricin Pharmaceutical

Jiangsu Tricin Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of high-end active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a strong focus on therapeutic areas including oncology, antiviral treatments, and cardiovascular health, producing complex small molecule drugs. Tricin operates state-of-the-art facilities that comply with international GMP standards, including certifications from the US FDA and EU authorities. In addition to its own product portfolio, the company provides comprehensive CDMO services to global pharmaceutical partners, ranging from process development to commercial production. Their business model integrates R&D innovation with efficient manufacturing to serve both domestic and international markets.